Most of the interactions which have been documented with alprazolam are with prescription drugs that modulate CYP3A4 action. Compounds which are inhibitors or inducers of CYP3A can be expected to increase or lower plasma alprazolam concentrations, respectively. Drug products which were analyzed in vivo, along with their effect on expanding alprazol